Uterine Testing for IVF Failures: Dr. Travis McCoy’s Insights

Dr. Travis McCoy explains how uterine testing after failed IVF cycles identifies endometriosis, bacterial imbalances, and implantation timing issues. Key tests include Receptiva (endometriosis markers), Emma-Alice (bacterial analysis), and ERA (implantation window timing). Endometriosis affects 50-70% of fertility patients, altering uterine receptivity.

---

Key Takeaways

Endometriosis’ Role in IVF Implantation Failure

Undiagnosed endometriosis contributes to 50-70% of fertility issues. The Receptiva test detects inflammation markers in the endometrium, confirming endometriosis’ impact on implantation success. Hormonal or surgical treatments can restore uterine function in 80-90% of cases.

Uterine Bacterial Imbalances Affecting IVF

The Emma-Alice test identifies harmful vaginal/uterine bacteria that reduce implantation rates. Probiotic therapy or targeted antibiotics restore microbial balance, improving pregnancy outcomes by 30-40% in treated patients.

ERA Test for Personalized Embryo Transfer Timing

Endometrial Receptivity Analysis (ERA) identifies individual implantation windows, shifting transfer timing by 1-2 days. This personalized approach improves success rates by 25-30% in patients with prior IVF failures.

Treatment Timelines for Uterine Factors

Endometriosis treatment requires 3 months of hormonal therapy or surgery for full uterine recovery. Bacterial imbalances respond to 2-4 weeks of probiotics/antibiotics, while ERA adjustments enable immediate transfer timing optimization.

Insurance Coverage for Uterine Testing

Most insurers don’t cover Receptiva, Emma-Alice, or ERA tests. However, these tests are cost-effective when done before embryo transfers in patients with limited embryo reserves, preventing unnecessary cycles.

---

Source: Read full article